Antibody to telomerase reverse transcriptase
US7285639B2 · kind B2 · utility
12Cited by
34References
11Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Jan 18, 2002 |
| Grant date | Oct 23, 2007 |
| Priority date | — |
| Expiry date | Mar 23, 2023 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2310/315
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention is directed to monoclonal or recombinant antibodies or fragments thereof that bind to human telomerase reverse transcriptase (hTRT) protein. The present invention is also directed to methods of identifying or detecting hTRT polypeptides in biological samples. The invention is further directed to methods of generating antibodies that specifically bind to hTRT protein.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.